Seems that a revenue stream comes from the patents given...it also seems a good thing that the FDA has their eyes open to the research end of this company's product...then there's the "University of Michigan cancer center" end where you can figure there's new information derived from this affiliation...imo, seems many arrows are pointed toward the success of this MSA research in building a steady stream of income, oh, also, way back in 2000 this stock actually was in or around 350 a share, so the value is there plus the management has led the company toward greener pastures, at one time. Since the company has been beaten down by one circumstance or another, perhaps accumulating a few shares would add to ones own value. One other post points at the technical avenue as looking in the right direction to support owning a few more...the fundamental aspect is also pointing toward ownership of a few shares of this stock, but only time will tell whether this stock reaches a lofty level of value...:)
News 
Market Data 
Discover 
